Genomics Services Cogenics offers a comprehensive suite of genomic services including DNA and RNA extraction, genotyping, sequencing, and gene expression analysis, presenting a broad cross-sell opportunity to research organizations seeking end-to-end genomics capabilities.

Pharmacogenomics Focus Strength in pharmacogenomics discovery and validation suggests potential for collaborations with biotech and pharma companies pursuing personalized medicine programs, enabling joint projects on biomarkers and companion diagnostics.

Global Footprint Operations in the US, UK, France, and Germany provide regional access and timing advantages for multinational clinical and translational research programs, allowing tailored service offerings and faster project onboarding across Europe and North America.

Mid-market Scale With revenue in the mid tens of millions and a team size under 50 in this listing, Cogenics presents a scalable partner for mid-sized biotech firms seeking flexible engagement models, rapid delivery, and cost-effective genomics support.

Lifecycle Support Additional capabilities in biorepository/biobanking and cell bank characterization indicate opportunities to upsell ongoing sample management and quality-control services to labs building long-term specimen programs.